Cases & Deals

XIO acquires Lumenis for approximately $510 million, $14 per share, in cash

Clients XIO Group

Jones Day advised XIO Group in its acquisition of Lumenis Ltd., the world's largest energy-based medical company for surgical, ophthalmology, and aesthetic applications, for $14 per share in cash, for an aggregate purchase price of approximately $510 million. Jones Day also assisted with the financing which consisted of a term loan, revolving loan, and a bridge loan provided by Mizrahi Tehafot Bank Ltd. ZELPEL acted as lead counsel with respect to the Israel law facility agreement.

In addition to M&A representation, Jones Day provided intellectual property and health care advice regarding this transaction.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.